Fisher unit pursues RNA research

NH Business Review Staff,

A business unit of Fisher Scientific is teaming up with Alcon Incorporated to use RNA research to develop drugs that can be delivered through the eye.

Dharmacon, the Colorado based business unit of Fisher Biosciences, itself a unit of the Hampton-based corporation, specializes in making products that interfere with RNA, thus silencing disease-causing genes. This RNA interference (RNAi) enables it to target organisms that previously were not treatable by drugs.

Alcon, a German company with headquarters in Dallas, Texas, is known for its eye care products.

Financial terms of the multi-year deal were not disclosed. — NHBR STAFF REPORT

Categories: News

More news from NHBR:

177683682169e860d5e1d1c
Health, News

North Country Healthcare report listening sessions

North Country Healthcare on Monday, April 13, released a report summarizing feedback from a series of community listening sessions held earlier this year across the region, highlighting widespread concern about access to care, staffing and communication, along with strong support for keeping local hospitals open.

Assisted Living Facility
News, Nonprofits

Morrison Hospital Association files for bankruptcy

Morrison Hospital Association, a nonprofit senior care provider in northern New Hampshire, filed for Chapter 11 bankruptcy protection April 10, citing mounting debt — including a nearly $23 million federal loan — and lingering financial effects from the COVID-19 pandemic.